Coverage depends heavily on your specific plan and your diagnosis
In addition to a heightened risk of pancreatitis and gallstones, patients have also suffered from: Severe and Prolonged Vomiting While nausea and occasional vomiting are common side effects of GLP-1 agonists, some patients experience frequent vomiting that lasts for two weeks or more
Davis DB, Khoraki J, Ziemelis M, Sirinvaravong S, Han JY, Campos GM
And, if you live in Los Angeles (or any major metropolitan city, honestly), seemingly half of everyone you know has or is currently taking one of these medications for their weight loss-boosting effectseven if they swear their leaner frame is exclusively due to drinking more water and doing pilates. Glucagon-like peptide-1 receptor agonists (GLP-1RAs) were initially developed and approved to treat type 2 diabetes and obesity by helping to regulate blood glucose levels, mimicking the effects of GLP-1, a naturally occurring hormone in the body that regulates digestion, appetite, and blood sugar
What work is that doing
A study published in Clinical Interventions in Aging confirmed that using a GHRH analog (like CJC1295) with a GHRP (like Ipamorelin) can significantly elevate IGF-1 levels over time (Khorram, CIA )